Investigating the role of a protein in pancreatic cancer development
Role of Gastrokine 2 in pancreatic cancer development
This study is looking at a protein called Gastrokine 2 that is usually found in the stomach, to see how it might affect the growth of pancreatic cancer, with the hope of finding new ways to help people with this type of cancer.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10884874 on NIH RePORTER |
What this research studies
This research focuses on understanding how Gastrokine 2 (Gkn2), a protein normally found in stomach cells, may influence the development of pancreatic cancer. Researchers will explore how Gkn2 expression changes in pancreatic cancer cells and its potential role in cancer progression. By examining the mechanisms behind Gkn2's involvement, the study aims to uncover new insights that could lead to better treatment strategies for pancreatic cancer patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pancreatic ductal adenocarcinoma or those at high risk for developing this type of cancer.
Not a fit: Patients with other types of cancer or those without pancreatic cancer risk factors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic targets for pancreatic cancer, potentially improving survival rates.
How similar studies have performed: While the role of Gastrokine 2 in pancreatic cancer is still being explored, similar studies on other proteins have shown promise in understanding cancer mechanisms and developing new treatments.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Bell, Whitney Jean — Univ of North Carolina Chapel Hill
- Study coordinator: Bell, Whitney Jean
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.